Methotrexate-associated lymphoproliferative disorder masquerading as interstitial lung disease [3]

Histopathology

Volumn 51, Issue 5, 2007, Pages 709-712

  Jois, R N ^a   Gaffney, K ^a   Cane, P ^b   Nicholson, A G ^c   Wotherspoon, A C ^c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE;

ADULT; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; LUNG FUNCTION; LYMPHOPROLIFERATIVE DISEASE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; THORAX RADIOGRAPHY;

ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; MIDDLE AGED; THORAX;

EID: 35348876079     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02830.x     Document Type: Letter

References (11)

1. Kamel OW, van de Rijn M, LeBrun DP et al. Lymphoid neoplasm's in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum. Pathol. 1994 25 638 643.
2. Bachman TR, Sawitzke AD, Perkins SL et al. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum. 1996 39 325 329.
3. Dawson TM, Starkebaum G, Wood BL et al. Epstein-Barr virus, methotrexate and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series. J. Rheumatol. 2001 28 47 53.
4. Mariette X, Cazals-Hatem D, Warszawki J et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002 99 3909 3915.
5. Kamel OW, van de Rijn M, Weiss LM et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N. Engl. J. Med. 1993 328 1317 1321.
6. Salloum E, Cooper DL, Howe G et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J. Clin. Oncol. 1996 14 1943 1949.
7. Georgescu L, Quinn GC, Schwartzmann S et al. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin. Arthritis Rheum. 1997 26 794 804.
8. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004 50 1740 1751.
9. Ebeo CT, Girish MR, Byrd MR et al. Methotrexate-induced pulmonary lymphoma. Chest 2003 123 2150 2153.
10. Ito I, Nagai S, Kitaichi M et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiological and pathologic study. Am. J. Respir. Crit. Care Med. 2005 171 632 638.
11. Sabourin JC, Kanavaros P, Briere J et al. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients. Am. J. Surg. Pathol. 1993 17 995 1002.